World’s first documented case of brain disease from fentanyl inhalation reported
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
On Apr. 26, 2024, an international team of researchers led by the National Cancer Institute (NCI) released an…
On Apr. 26, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BEQVEZ™ (fidanacogene…
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
On Apr. 15, 2024, scientists at University of California Riverside demonstrated a new, RNA-based vaccine strategy that is…
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
On Apr. 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Texas had reported…
On Apr. 1, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM) announced awards that support 11 projects in…
On Mar. 28, 2024, the American Chemical Society awarded The Priestley Medal to Carolyn R. Bertozzi “to recognize…
On Mar. 28, 2024, the Idaho State Department of Agriculture (ISDA) announced it had identified a highly pathogenic…
On Mar. 27, 2024, researchers from Trinity College Dublin announced they had recovered remarkably preserved microbiomes from two…
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pemgarda…
On Mar. 21, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
On Mar. 13, 2024, an unassuming brown bovine from the south of Brazil has made history as the…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Mar. 8, 2024, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionメs (CDC) Advisory Committee on Immunization Practices…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Feb. 21, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…